Upgrade to SI Premium - Free Trial

Amarin (AMRN) Q4 'Very Strong', Seen as 'Great Tuck-In' for Big Pharma - Jefferies

February 27, 2019 12:52 PM
Jefferies analyst Michael Yee weighed in on Amarin Corporation (NASDAQ: AMRN) following "very strong" Q4 results as the company is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Rumors

Next Articles